Tata Capital Unlisted Shares

Tata Capital-backed Oncocare Centre raises $18 million funding led by Elevation Capital

Money control

2 min read

Tata Capital-backed Oncocare Secures $18M from Elevation Capital.

Expert Analysis:

Funding Secured: MOC Cancer Care & Research Centre, backed by Tata Capital, raised $18 million from Elevation Capital for expansion.
Established in 2018: MOC, founded by four oncologists, operates 24 centers across multiple cities with 47 oncologists, administering 65,000 chemotherapy sessions annually and treating 4.5 lakh patients, making it likely India's largest oncology-driven business; after remaining bootstrapped for 5.5 years, it now ensures profitable, affordable cancer care.
Expansion & Merger: In May 2024, MOC expanded into Gujarat through a merger with Hemato Oncology Clinic (HOC).
Funding & Growth Plans: Raised $10M from Tata Capital in 2023; with $18M funding, plans expansion in North India and development of oncology services.
Strong Growth & Stability: Achieved a 46% CAGR over five years, with a brief COVID slowdown but remained debt-free.
Cancer Care Challenges: India faces 1.5M new cancer cases annually, with inadequate infrastructure, high costs, and a lack of personalized care.
MOC’s Solution: Operates safety-equipped community cancer centers, saving patients 20-30% in costs while offering nutrition guidance, physiotherapy, and genetic counseling.
Future Plans: New funding will enhance infrastructure, enable large-scale clinical trials, and expand access to advanced cancer care across India.

Takeaways

MOC expands with $18M, sustaining profitability, 46% CAGR, and pioneering cost-effective oncology care while enhancing research, accessibility, and patient services.

Invest in the Future

Act now and capitalize on the potential growth of this unlisted share

Precize Daily Pulse

The latest news in the world of Unlisted Shares, summarised by our experts.

The next generation of asset classes in India

Company

Institutions Retail Care

Resources

Blogs News FAQs

Legal

Our Office

Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093

Find us on Google

support@precize.in

+91 7738336457

All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.

The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.

Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.

The website will be updated regularly.